SCN8A encephalopathy could be improved with a treatment already approved for other uses.
As research in rats reveals a key brain pathway, neuroscientists contemplate how to translate findings in animals to understanding of human compulsions involving food or drugs.
People with mild cognitive impairment don’t always receive the same, established medical treatment that patients with normal cognitive functioning get when they have a heart attack.
A Phase I clinical trial, using a structurally related analog of the compound, is currently enrolling patients.
Findings implicate a specific type of immune cell behind heterotopic ossification--and present a potential target for treatment.
A team of researchers conduct a meta-analysis of studies to assess the safety of a commonly used contrast agent for patients with chronic kidney disease.